Accès gratuit
Numéro
Med Sci (Paris)
Volume 28, Numéro 11, Novembre 2012
Page(s) 929 - 931
Section Nouvelles
DOI http://dx.doi.org/10.1051/medsci/20122811009
Publié en ligne 12 novembre 2012
  1. Akhtar-Zaidi B, Cowper-Sal-Lari R, Corradin O, et al. Epigenomic enhancer profiling defines a signature of colon cancer. Science 2012 ; 336 : 736–739. [CrossRef] [PubMed]
  2. Van Engeland M, Derks S, Smits KM, et al. Colorectal cancer epigenetics: complex simplicity. J Clin Oncol 2011 ; 29 : 1382–1391. [CrossRef] [PubMed]
  3. Bell O, Tiwari VK, Thomä NH, Schübeler D. Determinants and dynamics of genome accessibility. Nat Rev Genet 2011 ; 12 : 554–564. [CrossRef] [PubMed]
  4. Ong CT, Corces VG. Enhancer function: new insights into the regulation of tissue-specific gene expression. Nat Rev Genet 2011 ; 12 : 283–293. [CrossRef] [PubMed]
  5. Heintzman ND, Stuart RK, Hon G, et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 2007 ; 39 : 311–318. [CrossRef] [PubMed]
  6. Ernst J, Kheradpour P, Mikkelsen TS, et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 2011 ; 473 : 43–49. [CrossRef] [PubMed]
  7. Heintzman ND, Hon GC, Hawkins RD, et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 2009 ; 459 : 108–112. [CrossRef] [PubMed]
  8. Lupien M, Eeckhoute J, Meyer CA, et al. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 2008 ; 132 : 958–970. [CrossRef] [PubMed]
  9. Creyghton MP, Cheng AW, Welstead GG, et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci USA 2010 ; 107 : 21931–21936. [CrossRef]
  10. Rada-Iglesias A, Bajpai R, Swigut T, et al. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 2011 ; 470 : 279–283. [CrossRef] [PubMed]